psychedelics investing Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy
psychedelics investing Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
psychedelics investing Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
psychedelics investing A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
psychedelics investing Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
psychedelics investing Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
psychedelics investing Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
psychedelics investing Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
psychedelics investing Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
psychedelics investing Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026
psychedelics investing Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
psychedelics investing Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
psychedelics investing Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for July 22nd & 23rd
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for July 22nd & 23rd
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for July 22nd & 23rd
Metalsource Mining Identifies High Priority Drill Targets Across 2.4 Kilometres to Drive the Next Phase of Exploration at Silver Hill
Skyharbour Signs Letter of Intent with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin
